808MO Paclitaxel with or without pazopanib in ovarian cancer patients with relapse during bevacizumab maintenance therapy: The GINECO randomized phase II TAPAZ study

Authors :: Cyril Abdeddaim
J. Lequesne
Dominique Spaeth
L. Bengrine Lefevre
D. Petran
Benoit You
Dominique Berton
Fanny Pommeret
Michel Fabbro
M. Cancel
F. Joly Lobbedez
M-C. Kaminsky-Forrett
Alain Lortholary
Anne Floquet
Hugues Bourgeois
Amélie Anota
J. Martin-Babau
P-E. Brachet
M. Provansal Gross
A. Puszkiel
Source :: Annals of Oncology. 31:S611-S612
Publication Year :: 2020
Publisher :: Elsevier BV, 2020.

Subjects :: Oncology
medicine.medical_specialty
Bevacizumab
business.industry
Hematology
medicine.disease
Pazopanib
chemistry.chemical_compound
Paclitaxel
chemistry
Maintenance therapy
Internal medicine
Medicine
business
Ovarian cancer
medicine.drug

Full Text Access

Tools